Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Verona Pharma
Verona Pharma
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Verona Pharma gets new CEO and COO
Respiratory-focused biopharma has appointed David Zaccardelli as President and CEO, and Mark Hahn as COO
Verona Pharma makes two senior appointments
Nina Church joins as Executive Director of Global Clinical Development and Nancy Herje as Senior Director of Clinical Operations
Regulatory
Verona gets EU patent for ensifentrine formulation extended to 2035
Drug by the British company is in Phase 2b clinical trials for chronic obstructive pulmonary disease
Recruitment
Verona Pharma announces departure of Chief Medical Officer
Pharmaceutical
Verona Pharma appoints Vice President of Regulatory Affairs
Regulatory
Pharmacokinetic clinical study initiated by Verona Pharma
Verona Pharma initiates US clinical pharmacokinetic study for RPL554 following acceptance of an investigational new drug (IND) application by the US Food and Drug Administration (FDA)
Quintiles outsource Verona COPD and cystic fibrosis therapeutics
Verona Pharma enters global strategic clinical development services agreement with QuintilesIMS for RPL554
Subscribe now